Coming October 30: SABCS releases its session titles, and the full abstracts follow on November 23. We’ll add the program and the organizations presenting it once they’re out.

Genomic and tumor testing at SABCS 2026

Dec 8–11, 2026 San Antonio, TX ~11k attendees Website

22 organizations at SABCS 2026 present work in genomic and tumor testing. 22 of them have their own page in this guide. As of Sep 27, 2026.

All 124 organizations at SABCS 2026 →

Showing 1–20 of 22 organizations
OrganizationSABCS 2026 Attendance
Agendia
Irvine, CA
Diagnostics
Genomic tests for early-stage breast cancer, including MammaPrint and BluePrint, that help clinicians weigh recurrence risk and choose treatment.
Booth
Exhibiting at Booth 1242
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Artera
Los Altos, CA
Diagnostics
Multimodal AI tests that read digitized pathology slides alongside clinical data to judge how aggressive a cancer is and who benefits from therapy.
Booth
Exhibiting at Booth 1544
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
ARTIDIS
Basel, Switzerland
Diagnostics
Nanotechnology-based analysis of biopsy tissue, paired with a data platform, to help guide treatment of solid tumors.
Booth
Exhibiting at Booth 849
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Ataraxis
New York, NY
Diagnostics
AI tests that read routine pathology slides and patient data to estimate outcomes and guide treatment in every subtype of invasive breast cancer.
Booth
Exhibiting at Booth 1524
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Diagnostics
Asuragen molecular diagnostic kits and software, including the QuantideX line for cancer monitoring and diagnosis, run on widely installed lab instruments.
Booth
Exhibiting at Booth 1430
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
BostonGene
Waltham, MA
Diagnostics
AI platform with its own CLIA lab that profiles tumors' molecular and immune features to guide therapy choices and help drug developers select trial patients.
Booth
Exhibiting at Booth 1248
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Diagnostics
Molecular profiling company whose tissue and blood tests, backed by AI, map a tumor's DNA, RNA and proteins to guide cancer treatment.
Booth
Exhibiting at Booth 1215
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Diagnostics
Commercializing a test licensed from MD Anderson that scores endocrine activity in HR+/HER2- stage II–III tumors to guide therapy.
Booth
Exhibiting at Booth 1528
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Exact Sciences
Madison, WI
Diagnostics
Cancer screening and diagnostics company, now part of Abbott, known for the Oncotype DX breast recurrence test and the Cologuard screening test.
Booth
Exhibiting at Booth 843
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Diagnostics
Genomic profiling tests on tumor tissue and blood that help physicians choose cancer treatments and support drug research.
Booth
Exhibiting at Booth 1346
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Guardant Health
Palo Alto, CA
Diagnostics
Cancer testing company: blood tests for screening and recurrence monitoring, tissue and blood profiling to pick treatment, and data services for drug developers.
Booth
Exhibiting at Booth 814
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Hologic
Marlborough, MA
Diagnostics
Women's health technology company whose Breast Cancer Index test helps decide whether early HR+ breast cancer warrants hormone therapy beyond five years.
Booth
Exhibiting at Booth 915
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Inocras
San Diego, CA
Diagnostics
Whole-genome sequencing company using its own analytics to turn genome data into clinical and research insights for precision health.
Booth
Exhibiting at Booth 247
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
MultiplexDX
Bratislava, Slovakia
Diagnostics
Slovak developer of tumor tests that combine multiplex RNA FISH and RNA sequencing to measure several cancer markers at single-cell resolution.
Booth
Exhibiting at Booth 1350
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Myriad Oncology
Salt Lake City, UT
Diagnostics
Hereditary cancer risk and tumor genomic tests from Myriad Genetics, used from risk assessment and screening through treatment and survivorship.
Booth
Exhibiting at Booth 215
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Natera
San Carlos, CA
Diagnostics
Cell-free DNA blood tests for cancer: tumor-informed MRD monitoring with Signatera, treatment response, genomic profiling and hereditary risk.
Booth
Exhibiting at Booth 909
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
NeoGenomics
Fort Myers, FL
Diagnostics
Cancer diagnostics company running CLIA-certified labs that offer a broad oncology testing menu to oncologists, pathologists, hospitals and drug developers.
Booth
Exhibiting at Booth 242
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
PreludeDx
Laguna Hills, CA
Diagnostics
Genomic tests that help decide on surgery and radiation: DCISionRT in DCIS and AidaBreast in early invasive breast cancer.
Booth
Exhibiting at Booth 1208
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Reveal Genomics
Barcelona, Spain
Diagnostics
Barcelona company behind HER2DX, a genomic test that estimates recurrence risk and treatment response in early HER2-positive breast cancer.
Booth
Exhibiting at Booth 1252
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Tempus
Chicago, IL
Diagnostics
AI-driven precision medicine company offering genomic testing and data tools to physicians and helping drug developers with discovery and trials.
Booth
Exhibiting at Booth 1332
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm

Explore the full SABCS 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full SABCS 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers in genomic and tumor testing

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Browse SABCS 2026 by

Exhibit hall

Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published exhibitor list. Submit a correction